Ozempic’s Canadian Patent: A Critical Oversight with Huge Consequences
Ozempic’s Canadian Patent: A Critical Oversight with Huge Consequences Novo Nordisk’s semaglutide-based drugs—Ozempic and Wegovy—have dominated Canada’s diabetes and obesity treatment market. In 2024, Ozempic ranked as the best-selling drug in the country, with retail